  Press Releases |
 |
|
|
Press Releases
 March 29, 2010
 Molecular Biometrics Appoints Sales Executive to Support Global Launch of ViaMetrics-E™
 Click here for full Press Release
March 22, 2010
Molecular Biometrics Receives Frost & Sullivan Technology Innovation Award
Click here for full Press Release
March 3, 2010
Molecular Biometrics Announces Launch of ViaMetrics-E™: New procedure to enhance infertility treatment outcomes
now available in select international markets
Click here for full Press Release
January 13, 2010
Molecular Biometrics Closes $12.5 Million Series B Equity Funding
Click here for full Press Release
October 21, 2009
Molecular Biometrics scientific advisory board chair, Emre Seli, MD, receives 2009 ASRM New Investigator Award.
Click here for full Press Release
October 21, 2009
Six new studies demonstrate a close correlation between embryo viability assessment using novel metabolomic profiling technologies and IVF pregnancy outcomes.
Click here for full Press Release
June 30, 2009
New studies demonstrate the accuracy of novel, metabolomic profiling technology in predicting the viability of frozen and advanced stage embryos.
Click here for full Press Release
June 16, 2009
New data demonstrate potential for early detection of alzheimer's disease using new diagnostic technology, which could lead to improved treatment. Groundbreaking research published in the Journal of Alzheimer’s Disease.
Click here for full Press Release
May 21, 2009
Molecular Biometrics receives 2009 Genesis Technology Transfer Award, presented by BIOQuebec.
Click here for full Press Release
November 11, 2008
Studies Demonstrate Accuracy of Novel, Metabolomic Profiling Technology in Predicting Reproductive Potential of Embryos for IVF.
Click here for full Press Release
November 10, 2008
Safeguard Scientifics and Oxford Bioscience Partners Co-Lead $12 Million Series A Financing for Molecular Biometrics
Click here for full Press Release
August 5, 2008
Molecular Biometrics Announces Results of Parkinson’s Disease Research ane Receipt of Grant From
Michael J. Fox Foundation to Advance Diagnostic Technology.
New research demonstrates proof-of-concept for diagnosing Parkinson’s disease using non-invasive, biospectroscopy technology.
Click here for full Press Release
July 7, 2008
Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology. Molecular Biometrics presents scientific evidence supporting accuracy of its biospectroscopy-based metabolomics platform at major international conference.
Click here for full Press Release
June 3, 2008
Molecular Biometrics announces the addition of three senior commercial executives in sales, marketing and international distribution, and the addition of two new scientists to its R&D team.
Click here for full Press Release
January 23 , 2008
Molecular Biometrics hires Denny Sakkas, PhD, renowned Yale embryologist and international thought-leader, as Chief Scientific Officer; opening U.S. research Facility
Click here for full Press Release
October 15, 2007
Metabolomic Profiling Accurately Identifies Stages of Oocyte Maturation in IVF
Click here for full Press Release
September 5, 2007
Molecular Biometrics to Provide Update on Its Metabolomics Platform and Lead Product for
Non-Invasive Embryo Viability Assessment in IVF at Red Herring's Montreal Technology Conference Click here for full Press Release
June, 2007
Researchers to Report Progress Using Metabolomic Profiling of Biomarkers as Assisted Reproductive Procedure in Assessing Embryo Viability for In Vitro Fertilization
Click here for full Press Release
May, 2007
Molecular Biometrics Identifies Promising Biomarkers for Diagnosis of Parkinson's Disease
Click here for full Press Release
April, 2007
Molecular Biometrics to Open Research and Development Facility in Montreal
Click here for full Press Release
December, 2006
Molecular Biometrics Secures Broad Patent Portfolio for Metabolomics Technology Platform in All Biomedical Applications
Click here for full Press Release
October, 2006
Molecular Biometrics Presents Results of a Pilot Study Assessing Use of Metabolomic Profiling in Male Infertility at American Society of Reproductive Medicine's 62nd Annual Meeting
Click here for full Press Release
|
 |